July 3, 2024 July 3, 2024Categories Coming SoonComing Soon: PrE1702 Real-World Data Study for Patients with EGFR-Mutated Non-Small Cell Lung Cancer Not Enrolled in Clinical TrialsThis innovative real-world data study is developing an infrastructure to conduct a study comparing outcomes in patients with EGFR-mutated NSCLC receiving osimertinib with or without chemotherapy and not enrolled in a clinical trial
June 13, 2024 June 13, 2024Categories Coming SoonNow Enrolling: EA7222 for Patients with Advanced Soft Tissue SarcomaThis randomized phase 3 trial is comparing treatment with chemotherapy alone or with immunotherapy